Compare AU

Compare EX20 vs. EDOC

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Australian Ex-20 Portfolio Diversifier ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Australian Ex-20 Portfolio Diversifier ETF (EX20) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

EX20

EDOC

Popularity

Low

Low

Pearlers invested

21

10

Median incremental investment

$1,993.50

$705.01

Median investment frequency

Monthly

Monthly

Median total investment

$2,428.92

$612.87

Average age group

> 35

> 35


Key Summary

EX20

EDOC

Strategy

EX20.AX was created on 2016-10-05 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 342.68m in AUM and 180 holdings. EX20.AX aims to track the performance of an index (before fees and expenses) comprising the 180 largest stocks listed on the ASX, after excluding the 20 largest, based on their market capitalisation.

EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses.

Top 3 holdings

SUNCORP GROUP LTD (2.54 %)

COCHLEAR LTD (2.45 %)

BRAMBLES LTD (2.39 %)

INSULET CORP (8.47 %)

BOSTON SCIENTIFIC CORP (8.24 %)

ABBOTT LABORATORIES (7.76 %)

Top 3 industries

Materials (16.44 %)

Financials (13.89 %)

Industrials (13.22 %)

Health Care (75.06 %)

Other (24.70 %)

Consumer Staples (14.33 %)

Top 3 countries

Australia (89.38 %)

United States (5.50 %)

New Zealand (3.83 %)

United States (77.51 %)

China (13.32 %)

Japan (4.67 %)

Management fee

0.25 %

0.67 %


Key Summary

EX20

EDOC

Issuer

BetaShares

BetaShares

Tracking index

Nasdaq Australia Completion Cap Index - AUD

Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net

Asset class

ETF

ETF

Management fee

0.25 %

0.67 %

Price

$22.49

$10.13

Size

$357.996 million

$1.525 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

3.56 %

- %

Market

ASX

ASX

First listed date

07/10/2016

29/03/2022

Purchase fee

$6.50

$6.50


Community Stats

EX20

EDOC

Popularity

Low

Low

Pearlers invested

21

10

Median incremental investment

$1,993.50

$705.01

Median investment frequency

Monthly

Monthly

Median total investment

$2,428.92

$612.87

Average age group

> 35

> 35


Pros and Cons

EX20

EDOC

Pros

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

  • Higher exposure to US market

Cons

  • Lower exposure to US market

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

EX20

EDOC

Higher exposure to AU market

Lower exposure to AU market

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home